Study of Anemia in Chronic Kidney Disease (CKD) Among High-Risk Hypertensive and Diabetic Patients in Pakistan

Hoffmann-La Roche246 enrolled

Overview

The purpose of this study is to evaluate the prevalence of CKD-related anemia at an early stage through screening of high-risk patients in Pakistan at the level of physicians, cardiologists, and diabetologists. The information gathered may serve as a foundation in formulating national guidelines for better early diagnosis and management of patients with CKD.

Study Type

OBSERVATIONAL

Enrollment

246

Conditions

Anemia, Diabetes, Kidney Disease, Chronic, Hypertension

Eligibility

Sex: ALLMin age: 40 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age greater than or equal to 40 years * Known hypertension and/or diabetes for at least 3 years * Positive dipstick test result for proteinuria Exclusion Criteria: * Known CKD * Receiving erythropoietin * Blood transfusion within 8 weeks * History of acute or chronic bleeding, hemolysis, or hemoglobinopathy

Locations (3)

Unnamed facility

Islamabad, Pakistan

Unnamed facility

Karachi, Pakistan

Unnamed facility

Lahore, Pakistan

Outcomes

Primary Outcomes

Number of patients with anemia secondary to CKD

Time frame: Up to 12 months

Secondary Outcomes

Use of treatment modalities for the management of anemia secondary to CKD

Time frame: Up to 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.